Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2024-06-03
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing an Intervention Facilitating the Use of Eye Contact in Adults With Autism
NCT06924008
Course of Face-to-face Interactions in Adults With Autism
NCT06925308
Autism and Attachment. An Explorative Study of Attachment Styles in Autistic Adults.
NCT06375226
Oxytocin Modulates Eye Gaze Behavior During Social Processing
NCT03293511
Autism in Adult Patients and the Effects on Caregivers
NCT00367107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To get insight in the subjective eye contact experiences of adults with ASD compared to adults without ASD, a hermeneutic phenomenological design using Multisite Qualitative Analysis (MSQA) and the PRICE-model for saturation during data analysis were used. MSQA enables the highest qualitative accuracy, the gathering of rich context-specific insights and maximizing the applicability. Semi-structured interviews was chosen for data collection and analysis because adults with ASD attach importance to on the one hand having the space to share their experiences in their own way, but on the other hand need frameworks to know what is asked of them. Hermeneutic phenomenological approach, grounded in philosophical concepts developed by Heidegger and Gadamer, made it possible to create meaning on how people experience a situation or phenomenon, such as eye contact, in a flexible and practical way.
Multisite design was chosen in response to criticism that single-site findings would limit the relevance and transferability and reliability to other settings. The Consolidated criteria for reporting qualitative studies (COREQ) checklist was used for reporting the research data. For the checklist. In addition, the Standards for Reporting Qualitative Research (SRQR) checklist was used. The research design was developed in collaboration with three adults with ASD and three adults without ASD, in order to include relevant information from the perspective of the target groups.
The semi-structured interviews were conducted using a topic list. This topic list consisted of the following sub questions:
Meaning:
* What do you think is the meaning of the term eye contact?
* In your opinion, are there different ways of making eye contact? If so, which?
* What do you think about the opinion that eye contact is abnormal in autism?
Development:
* Was the subject of eye contact brought up in your youth? If so, how?
* Did you learn how to make eye contact?
* Does your experiences with eye contact influenced how you lived your life? How?
Initiative to eye contact:
* Does it matter to you how others make eye contact with you? Why?
* Does the way you make eye contact with others depend on the situation or the person? Why?
* Do you adjust your eye contact to situations and/or people?
Interpretation of eye contact:
* Are there for you different ways of having eye contact? Which one?
* Are there for you different meanings of eye contact? Which one?
Dealing with eye contact:
* How do you make eye contact when interacting with others? Does that happen automatically?
* Do you consciously think about having eye contact? How come?
* How do you experience having eye contact with others? How come?
Wishes:
Would you like your eye contact with others to be different?/Do you need to improve the eye contact you have with others? If not, why? If so, why?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autism
The group of adults with ASD consisted of participants who were receiving outpatient treatment at one of three specialized centers for ASD, located in Deventer, Rotterdam or Amsterdam in the Netherlands.
No interventions assigned to this group
Neurotypicals
The group of adults without ASD consisted of participants who were never diagnosed with autism and lived in the Netherlands.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving outpatient treatment at a specialized autism center in the Netherlands
* Being able to understand the themes to be discussed
* Motivation to participate in the research
* Being able to understand the themes to be discussed
* Motivation to participate in the research
Exclusion Criteria
* Use of alcohol and/or recreational drugs during the study
* Too much mental instability to participate in the study
* Familiarity with treatment in intellectual disability care
Adults without autism
* Insufficient command of the Dutch language
* Use of alcohol and/or recreational drugs during the study
* Too much mental instability to participate in the study
* Familiarity with treatment in intellectual disability care
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dimence Groep
UNKNOWN
UMC Utrecht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jos Boer
MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nynke Boonstra, Professor
Role: STUDY_CHAIR
UMC Utrecht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dimence Groep
Deventer, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dimence Groep
Identifier Type: OTHER
Identifier Source: secondary_id
55990
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.